Functional analysis of the molecular factors controlling Qa1-mediated protection of target cells from NK lysis

Journal of Immunology

Volumn 166, Issue 3, 2001, Pages 1601-1610

  Gays, F ^a   Fraser, K P ^a   Toomey, J A ^a   Diamond, A G ^a   Millrain, M M ^a   Dyson, P J ^a   Brooks, C G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; CELL RECEPTOR; GENE PRODUCT; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN QA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOLYSIS; GENETIC TRANSFECTION; MOLECULAR INTERACTION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL;

EID: 0035253569     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.3.1601     Document Type: Article

References (51)

1. In search of the 'missing self': MHC molecules and NK cell recognition
2. The CD94/NKG2 C-type lectin receptor complex
3. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
4. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
5. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
6. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b)
7. The Qa-1b molecule binds to a large subpopulation of murine NK cells
8. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells
9. Structural and functional characteristics of the class IB molecule, Qa-1
10. Identification of a Tap - Dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen
11. Dominance of a single peptide bound to the class I(B) molecule, Qa-1b
12. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide
13. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9
14. Nonstochastic coexpression of activation receptors on murine natural killer cells
15. Phenotypic and functional characterization of long-lived NK cell lines of different maturational status obtained from mouse fetal liver
16. Stochastic acquisition of Qa1 receptors during the development of fetal NK cells in vitro accounts in part but not in whole for the ability of these cells to distinguish between class I-sufficient and class I-deficient targets
17. +Ly-49- cells: A possible mechanism of tolerance during NK cell development
18. The majority of immature fetal thymocytes can be induced to proliferate to IL-2 and differentiate into cells indistinguishable from mature natural killer cells
19. Cloning and culturing of mouse NK cells
20. NK cells and LAK cells
21. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood
22. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids
23. NK susceptibility varies inversely with target cell class I HLA antigen expression
24. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
25. The mouse tumor cell lines EL4 and RMA display mosaic expression of NK-related and certain other surface molecules and appear to have a common origin
26. Quantitative studies of natural immunity to solid tumours in rats: Persistence of natural immunity throughout reproductive life, and absence of suppressor cells in infant rats
27. + T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules
28. Molecular mimicry mediated by MHC class Ib molecules after infection with Gram-negative pathogens
29. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon
30. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides
31. Intracellular transport of class I MHC molecules in antigen processing mutant cell lines
32. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells
33. Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells
34. The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand
35. Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49C
36. Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells
37. Altered natural killer cell repertoire in Tap-1 mutant mice
38. MHC class Ia molecules alone control NK-mediated bone marrow graft rejection
39. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
40. Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-γ/δ stimulated by nonpeptidic ligands
41. Phenotypic and cytokine analysis of human peripheral blood γδ T cells expressing NK cell receptors
42. Heat shock protein Hsp60-reactive γδ cells: A large, diversified T-lymphocyte subset with highly focused specificity
43. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
44. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
45. Ly-49CB6 NK inhibitory receptor recognizes peptide-receptive H-2Kb
46. Peptide specificity in the recognition of MHC class I by natural killer cell clones
47. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent
48. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40
49. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E
50. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G derived nonamer